H. C. Wainwright & Co. is the famous Corporate Investor, which was founded in 1868. The main office of represented Corporate Investor is situated in the New York. The company was established in North America in United States.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the H. C. Wainwright & Co., startups are often financed by Yelin Lapidot Investment House, Stop Sanfilippo, Shmuel Kabili. The meaningful sponsors for the fund in investment in the same round are ROTH Capital Partners, RBC Capital Markets, Nomura.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Medical Device, Wireless. Among the various public portfolio startups of the fund, we may underline Abeona Therapeutics, RedHill Biopharma The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 16-20 years to receive the investment from the fund.
The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2014.
Related Funds
Fund Name | Location |
Arvato Bertelsmann | Germany, Gütersloh, Nordrhein-Westfalen |
Daintree.VC | England, London, United Kingdom |
Dazu Venture Capital | China, Guangdong, Shenzhen |
Econnoa | - |
Foundation Holdings | Dubai, United Arab Emirates |
FSD Africa | Kenya, Nairobi, Nairobi Area |
Holman Growth Ventures | Pennsylvania, Philadelphia, United States |
Jieshi Investment | - |
Langdell Investments | California, Sunnyvale, United States |
Orlando Healthcare Ventures | - |
Realiza Business Angels | Spain, Valencia, Valencian Community |
Risk Management Solutions | California, Newark, United States |
RSL | - |
Speedshield | - |
Startup Loans UK | England, London, United Kingdom |
TOKYO SHOKO RESEARCH | Japan, Tokyo |
Various Investors | - |
West Capital Advisors | Chicago, Illinois, United States |
Xiamen Qingwa Juncheng Venture Capital | China, Fujian, Xiamen |
Zhuhai Chengdao Tianhua Investment | China, Guangdong, Zhuhai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.